Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
Standard Video
Actions
Overview
Conceptually Similar Documents
CP121635062 | AstraZeneca vaccine to remain authorized in Canada
CP123262421 | N.S. pauses use of AstraZeneca vaccine
CP118971421 | AstraZeneca vaccine authorized in Canada
CP123251321 | Ontario to get more than 250,000 AstraZeneca doses
CP120124021 | AstraZeneca COVID-19 vaccine now recommended for Canadian seniors
CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine
CP122017117 | AstraZeneca blood clot risk remains low: Tam
CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
CP123597771 | Second-dose choice likely for AstraZeneca recipients: Tam
CP118972171 | Newsroom Ready: AstraZeneca vaccine authorized in Canada
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
Source name:
The Canadian Press
Unique identifier:
CP120476771
Legacy Identifier:
n_COVID-Cda20210323T1400
Type:
Video
Duration:
1m47s
Dimensions:
1920px × 1080px 123.11 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
3/23/2021 2:00:00 PM
Display aspect ratio:
16:9
Tags
AstraZeneca
Canada
canada government
Coronavirus
COVID-19
doses
health
Ontario
Ottawa
safety
vaccine
vaccines